Wong L A, Mayer M L, Jane D E, Watkins J C
Laboratory of Cellular and Molecular Neurophysiology, NICHD, National Institutes of Health, Bethesda, Maryland 20892.
J Neurosci. 1994 Jun;14(6):3881-97. doi: 10.1523/JNEUROSCI.14-06-03881.1994.
Concentration jump responses to 5-substituted (S)-willardiines were recorded from dorsal root ganglion (DRG) and hippocampal neurons under voltage clamp. After block of desensitization by concanavalin-A, dose-response analysis for activation of kainate-preferring receptors in DRG neurons gave the potency sequence trifluoromethyl > iodo > bromo approximately chloro > nitro approximately cyano > kainate > methyl > fluoro > (R,S)-AMPA >> willardiine; EC50 values for the most and least potent willardiine derivatives, 5-trifluoromethyl (70 nM) and 5-fluoro (69 microM), differed 1000-fold. The potency sequence for equilibrium responses at AMPA-preferring receptors in hippocampal neurons was strikingly different from that obtained in DRG neurons: fluoro > cyano approximately trifluoromethyl approximately nitro > chloro approximately bromo > (R,S)-AMPA > iodo > willardiine > kainate > methyl. In hippocampal neurons EC50 values for the most and least potent willardiine derivatives, 5-fluoro (1.5 microM) and 5-methyl (251 microM), differed only 170-fold. Consistent with equilibrium potency measurements, in DRG neurons the kinetics of deactivation for willardiines, recorded following a return to agonist-free solution, were rapid for 5-fluoro (tau off = 43 msec) but slow for 5-iodo (tau off = 4.2 sec), while the opposite sequence was observed for hippocampal neurons, slow for 5-fluoro (tau off = 2.1 sec) and rapid for 5-iodo (tau off = 188 msec). The kinetics of recovery from desensitization showed comparable agonist- and cell-dependent differences. Structure-activity analysis for agonist responses recorded from DRG and hippocampal neurons suggests that for both kainate-preferring and AMPA-preferring receptors the binding of willardiines involves interactions with polar groups such that potency is related to ionization of the uracil ring, and hence the electron-withdrawing ability of the 5-position substituent. However, kainate-preferring receptors differ from AMPA-preferring receptors in possessing a lipophilic pocket that further enhances agonist potency by hydrophobic bonding of the 5-substituent. In contrast, AMPA-preferring receptors lack such a lipophilic site, and for 5-position substituents of the same electron-withdrawing ability, potency decreases with increase in size.
在电压钳制条件下,记录了背根神经节(DRG)和海马神经元对5-取代(S)-威拉地丁的浓度跃变反应。在用伴刀豆球蛋白A阻断脱敏后,对DRG神经元中优先激活海人藻酸受体的剂量反应分析得出效价顺序为:三氟甲基>碘>溴≈氯>硝基≈氰基>海人藻酸>甲基>氟>(R,S)-AMPA>>威拉地丁;最有效和最无效的威拉地丁衍生物,即5-三氟甲基(70 nM)和5-氟(69 μM)的半数有效浓度(EC50)值相差1000倍。海马神经元中优先激活AMPA受体的平衡反应效价顺序与DRG神经元中获得的顺序显著不同:氟>氰基≈三氟甲基≈硝基>氯≈溴>(R,S)-AMPA>碘>威拉地丁>海人藻酸>甲基。在海马神经元中,最有效和最无效的威拉地丁衍生物,即5-氟(1.5 μM)和5-甲基(251 μM)的EC50值仅相差170倍。与平衡效价测量结果一致,在DRG神经元中,回到无激动剂溶液后记录的威拉地丁失活动力学,5-氟(失活时间常数τoff = 43毫秒)很快,而5-碘(τoff = 4.2秒)很慢,而在海马神经元中观察到相反的顺序,5-氟(τoff = 2.1秒)很慢,5-碘(τoff = 188毫秒)很快。脱敏恢复动力学也显示出类似的激动剂和细胞依赖性差异。对DRG和海马神经元记录的激动剂反应进行的构效分析表明,对于优先激活海人藻酸受体和优先激活AMPA受体而言,威拉地丁的结合都涉及与极性基团的相互作用,因此效价与尿嘧啶环离子化有关,进而与5位取代基的吸电子能力有关。然而,优先激活海人藻酸受体与优先激活AMPA受体的不同之处在于,前者具有一个亲脂性口袋,通过5-取代基的疏水键合进一步增强激动剂效价。相反,优先激活AMPA受体缺乏这样一个亲脂性位点,对于具有相同吸电子能力的5位取代基,效价随尺寸增大而降低。